11/5/2010

The FDA is considering approval of a third drug for irritable bowel syndrome that will be for men and women. The antibiotic rifaximin or Xifaxan already is FDA-approved for traveler's diarrhea and is believed to restore a healthy balance of microbes in the digestive tract.

Related Summaries